Shortage of trial participants risks slowing progress, dementia charity warns

For the first time, the pipeline of innovative diagnostics and treatments for Alzheimer’s disease and other dementias is rapidly expanding. Yet this p…

Continue in Briflio to read, react, comment, and share.